Szmit, Z.; Frączkiewicz, J.; Salamonowicz-Bodzioch, M.; Król, A.; Ussowicz, M.; Mielcarek-Siedziuk, M.; Liszka, K.; Marschollek, P.; Gorczyńska, E.; Kałwak, K.
The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder. J. Clin. Med. 2022, 11, 5187.
https://doi.org/10.3390/jcm11175187
AMA Style
Szmit Z, Frączkiewicz J, Salamonowicz-Bodzioch M, Król A, Ussowicz M, Mielcarek-Siedziuk M, Liszka K, Marschollek P, Gorczyńska E, Kałwak K.
The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder. Journal of Clinical Medicine. 2022; 11(17):5187.
https://doi.org/10.3390/jcm11175187
Chicago/Turabian Style
Szmit, Zofia, Jowita Frączkiewicz, Małgorzata Salamonowicz-Bodzioch, Anna Król, Marek Ussowicz, Monika Mielcarek-Siedziuk, Karolina Liszka, Paweł Marschollek, Ewa Gorczyńska, and Krzysztof Kałwak.
2022. "The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder" Journal of Clinical Medicine 11, no. 17: 5187.
https://doi.org/10.3390/jcm11175187
APA Style
Szmit, Z., Frączkiewicz, J., Salamonowicz-Bodzioch, M., Król, A., Ussowicz, M., Mielcarek-Siedziuk, M., Liszka, K., Marschollek, P., Gorczyńska, E., & Kałwak, K.
(2022). The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder. Journal of Clinical Medicine, 11(17), 5187.
https://doi.org/10.3390/jcm11175187
